Smith Group Asset Management’s Amicus Therapeutics FOLD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-300
Closed -$3K 311
2021
Q4
$3K Hold
300
﹤0.01% 353
2021
Q3
$3K Hold
300
﹤0.01% 362
2021
Q2
$3K Hold
300
﹤0.01% 353
2021
Q1
$3K Sell
300
-13,148
-98% -$131K ﹤0.01% 317
2020
Q4
$1.09M Buy
13,448
+4,448
+49% +$361K 0.06% 97
2020
Q3
$127K Buy
9,000
+820
+10% +$11.6K 0.01% 189
2020
Q2
$123K Sell
8,180
-100
-1% -$1.5K 0.01% 186
2020
Q1
$77K Hold
8,280
﹤0.01% 226
2019
Q4
$81K Hold
8,280
﹤0.01% 249
2019
Q3
$66K Buy
8,280
+3,320
+67% +$26.5K ﹤0.01% 262
2019
Q2
$62K Hold
4,960
﹤0.01% 263
2019
Q1
$67K Sell
4,960
-16,000
-76% -$216K ﹤0.01% 284
2018
Q4
$201K Sell
20,960
-900
-4% -$8.63K 0.01% 242
2018
Q3
$264K Buy
21,860
+890
+4% +$10.7K 0.01% 235
2018
Q2
$328K Buy
20,970
+200
+1% +$3.13K 0.01% 215
2018
Q1
$312K Sell
20,770
-10,630
-34% -$160K 0.01% 219
2017
Q4
$452K Hold
31,400
0.01% 215
2017
Q3
$474K Hold
31,400
0.02% 218
2017
Q2
$316K Buy
+31,400
New +$316K 0.01% 241
2015
Q4
Sell
-105,780
Closed -$1.48M 491
2015
Q3
$1.48M Sell
105,780
-32,750
-24% -$458K 0.06% 156
2015
Q2
$1.96M Buy
138,530
+2,800
+2% +$39.6K 0.07% 149
2015
Q1
$1.48M Sell
135,730
-117,330
-46% -$1.28M 0.05% 156
2014
Q4
$2.11M Sell
253,060
-114,310
-31% -$951K 0.07% 150
2014
Q3
$2.19M Sell
367,370
-1,270
-0.3% -$7.56K 0.08% 154
2014
Q2
$1.23M Buy
368,640
+101,160
+38% +$338K 0.05% 175
2014
Q1
$554K Buy
+267,480
New +$554K 0.02% 195